Search for: "Ely Lilly" Results 1061 - 1080 of 2,157
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2024, 6:26 pm by Yosi Yahoudai
Ashton said.But now, that patient-doctor conversation has gone virtual.Last December, pharmaceutical company Eli Lilly announced its Zepbound injection – the sister medicine of its diabetes drug Mounjaro. [read post]
4 Aug 2010, 12:21 am by Kelly
Eli Lilly (Orange Book Blog) (Patently-O) (Gray on Claims) (Patent Docs)   Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
11 May 2011, 4:54 am by Marie Louise
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty:… [read post]
9 Feb 2009, 11:32 pm
Of Cymbalta, from biz.yahoo :US drug major Eli Lilly, continuing its fight against the generic launch of its second-largest selling drug, Cymbalta, sued Sun Pharma on December 4. [read post]
14 Oct 2015, 6:24 am by Michael Geist
  New rules on corporate lawsuits could result in more claims by foreign corporations against the Canadian government over national policies or court decisions (pharmaceutical giant Eli Lilly is already suing the government for $500 million over Canadian patent rulings) and an extension in the term of copyright beyond the international standard would lock down the public domain for decades and potentially cost Canadians hundreds of millions of dollars per year. [read post]
15 Apr 2021, 1:42 pm by Tom Lamb
But the pushback of these action dates for AbbVie’s Rinvoq, Pfizer’s Xeljanz and abrocitinib, and Eli Lilly’s Olumiant may be a sign that the FDA is preparing to hold an advisory committee of outside experts to review the risk/benefit profiles of JAK inhibitors for atopic dermatitis, according to Leerink analyst Geoffrey Porges. [read post]
31 Aug 2017, 9:53 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
16 Feb 2016, 1:43 am
  Mr Justice Arnold handed down his decision in the latest Eli Lilly and Actavis battle concerning lung cancer treatment pemetrexed disodium, in Actavis v Lilly [2016] EWHC 234, and Annsley takes the floor to recount this romantic, patent story,**********PREVIOUSLY, ON NEVER TOO LATENever too late 82 [week ending on Sunday 7 January] – PhD Student Seminar at CIPA | IP meets Antimonopoly law in Japan | German Federal Patent… [read post]
17 Sep 2022, 8:19 am
You just liked "ribs," but your feeling of liking it came, I'll bet, from having seen it so recently.And here's the Wikipedia entry for Tuinal, a Eli Lilly sleeping pill introduced in the late 1940s and now discontinued:Tuinal saw widespread abuse as a recreational drug from the 1960s through the 1980s. [read post]
5 Oct 2020, 5:17 am by Hayleigh Bosher
 Syoma the cat relaxing after a good read of TerrellImage: Olga GurgulaA significantly updated Chapter 9 on the construction of specifications and claims contains, inter alia, a detailed explanation on the modern approach and the Actavis v Eli Lilly case. [read post]
9 Dec 2009, 3:59 pm
: Roche v Cipla (Spicy IP) India, intellectual property and biotechnology industry – to protect, or not to protect (Biotech Blog) Italy: SPCs, competition and refusal to supply – Italian Competition Authority’s responses to ‘refusal to deal’ questionnaire (The SPC Blog) US: Ariad v Lilly – amicus briefs by Regents of University of California et al and various companies (Patent Docs) (Patent Docs) US: Ariad v Lilly – A look back at the… [read post]
3 Nov 2009, 2:35 pm by Tom Lamb
On November 2, 2009 Amylin Pharmaceuticals, Inc., and Eli Lilly and Company issued their joint statement in response to the FDA on BYETTA® (exenatide) injection. [read post]
21 Feb 2012, 9:22 am by Zoe Tillman
On the life sciences front, notably, the firm has represented Eli Lilly & Co. in a dispute with Amylin Pharmaceuticals Inc. over a new diabetes drug, winning the denial of a preliminary injunction that would have stood in the way of Eli Lilly’s marketing efforts. [read post]
12 Sep 2021, 10:37 am by Nassiri Law
Eli Lilly and Co say they were qualified and did well in their interviews, but were ultimately passed over for sales positions by younger, less qualified workers. [read post]
28 Mar 2010, 5:07 pm
Chantal writes to inform him as follows: "The almost endless series of olanzapine cases (inter alia Eli Lilly patent EP 0 454 436) has now produced an interesting sequel in the Netherlands. [read post]
26 Oct 2011, 7:59 am by Joe Consumer
  Zyprexa, you may know, has serious side-effects that can lead to  diabetes and its manufacturer, Eli Lilly, has been sued by tens of thousands of ill Zyprexa users, telling salespeople to downplay these side effects. [read post]
November 9, 2020 also saw the FDA’s issuance of an EUA for Eli Lilly’s antibody treatment for COVID-19. [read post]
17 Apr 2009, 12:00 am
Eli Lilly invalid (Patent Baristas), (Law 360) (Patent Docs) Gleevec / Glivec (Imatinib) – Novartis alpha crystalline form patent invalidated at pre – grant opposition (PatentCircle) Levaquin (Levofloxacin) - Daiichi Sankyo Co. [read post]